Healthcare Sector Stocks
The Healthcare sector has a total of 1060 stocks, with a combined market cap of $9.67 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 51.84.
Market Cap
9.67T
Revenue
4.66T
Profits
186.46B
PE Ratio
51.84
Profit Margin
4.00%
Dividend Yield
0.37%
1058 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.10T | -1.06% | 2,143,185 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 658.24B | 0.53% | 4,688,019 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 469.68B | 0.48% | 3,671,156 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 385.99B | 3.84% | 13,997,550 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 355.98B | -0.54% | 2,657,011 | 450.53B |
| 6 | NVS | Novartis AG | 303.81B | 1.24% | 998,181 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 263.84B | 1.77% | 3,453,437 | 61.37B |
| 8 | AMGN | Amgen Inc. | 239.09B | -0.36% | 2,101,324 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 232.26B | -0.09% | 1,535,341 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 212.51B | 3.71% | 15,544,583 | 50.34B |
| 11 | ABT | Abbott Laboratories | 200.95B | -0.46% | 7,503,762 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 184.47B | 1.38% | 4,630,428 | 30.46B |
| 13 | PFE | Pfizer Inc. | 162.84B | 2.15% | 31,916,206 | 63.70B |
| 14 | DHR | Danaher Corporation | 151.82B | 0.40% | 2,339,398 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 140.13B | 0.96% | 774,684 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 138.74B | 0.95% | 7,912,507 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 131.36B | -0.46% | 1,767,860 | 11.03B |
| 18 | SYK | Stryker Corporation | 126.81B | 0.85% | 2,202,658 | 25.84B |
| 19 | CVS | CVS Health Corporation | 118.82B | -1.29% | 4,102,123 | 412.65B |
| 20 | MDT | Medtronic plc | 116.66B | -1.89% | 6,799,550 | 36.36B |
| 21 | SNY | Sanofi | 110.09B | 0.72% | 1,240,433 | 55.89B |
| 22 | MCK | McKesson Corporation | 105.52B | 3.58% | 882,561 | 410.98B |
| 23 | GSK | GSK plc | 104.10B | 0.56% | 2,699,122 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 92.83B | -0.11% | 790,205 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 86.50B | -0.93% | 933,543 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 83.24B | 0.61% | 505,195 | 15.53B |
| 27 | CI | The Cigna Group | 73.81B | -0.40% | 1,644,811 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 72.26B | 1.73% | 17,365,006 | 21.00B |
| 29 | ARGX | argenx SE | 64.17B | 0.83% | 142,466 | 5.32B |
| 30 | MRNA | Moderna, Inc. | 63.41B | 14.36% | 50,059,781 | 2.23B |
| 31 | COR | Cencora, Inc. | 62.60B | 1.33% | 1,114,915 | 332.77B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 58.27B | 0.60% | 1,247,327 | 28.42B |
| 33 | CAH | Cardinal Health, Inc. | 55.33B | 2.39% | 1,335,051 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 52.38B | 0.41% | 2,389,752 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 51.69B | -0.50% | 1,207,518 | 22.48B |
| 36 | NTRA | Natera, Inc. | 48.53B | 2.74% | 1,734,016 | 2.71B |
| 37 | MDLN | Medline Inc. | 46.86B | 2.71% | 6,253,592 | 29.94B |
| 38 | HUM | Humana Inc. | 46.80B | 0.80% | 954,791 | 145.68B |
| 39 | RVMD | Revolution Medicines, Inc. | 45.31B | -0.09% | 1,379,507 | - |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 44.40B | 3.17% | 5,279,129 | 17.32B |
| 41 | HLN | Haleon plc | 44.39B | 0.20% | 5,581,418 | 14.80B |
| 42 | A | Agilent Technologies, Inc. | 43.71B | 0.87% | 2,425,945 | 7.23B |
| 43 | IDXX | IDEXX Laboratories, Inc. | 43.33B | -1.70% | 385,722 | 4.55B |
| 44 | ONC | BeOne Medicines AG | 42.79B | 1.18% | 396,289 | 6.13B |
| 45 | IQV | IQVIA Holdings Inc. | 42.70B | -0.32% | 901,364 | 16.98B |
| 46 | WAT | Waters Corporation | 40.72B | 0.90% | 631,816 | 4.64B |
| 47 | VEEV | Veeva Systems Inc. | 40.09B | -0.68% | 1,620,365 | 3.32B |
| 48 | RPRX | Royalty Pharma plc | 35.69B | 1.21% | 1,708,920 | 2.54B |
| 49 | ALC | Alcon Inc. | 35.35B | -0.45% | 816,271 | 10.86B |
| 50 | RMD | ResMed Inc. | 34.13B | 1.78% | 1,761,110 | 5.65B |
| 51 | ILMN | Illumina, Inc. | 33.97B | 0.79% | 1,918,028 | 4.49B |
| 52 | DXCM | DexCom, Inc. | 33.65B | -2.09% | 4,105,875 | 4.97B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 33.38B | -0.38% | 2,013,174 | 21.27B |
| 54 | BIIB | Biogen Inc. | 32.62B | 1.21% | 496,689 | 10.03B |
| 55 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.12B | 1.72% | 1,576,352 | 4.80B |
| 56 | CNC | Centene Corporation | 32.11B | -0.99% | 4,344,760 | 180.30B |
| 57 | ZTS | Zoetis Inc. | 31.94B | 0.16% | 3,479,421 | 9.53B |
| 58 | BNTX | BioNTech SE | 28.65B | 1.09% | 1,360,312 | 3.03B |
| 59 | MTD | Mettler-Toledo International Inc. | 28.10B | 0.24% | 116,914 | 4.13B |
| 60 | LH | Labcorp Holdings Inc. | 27.39B | -0.49% | 697,418 | 14.35B |
| 61 | INSM | Insmed Incorporated | 27.06B | -0.07% | 2,372,873 | 1.14B |
| 62 | DGX | Quest Diagnostics Incorporated | 26.99B | 0.26% | 709,150 | 11.56B |
| 63 | PHG | Koninklijke Philips N.V. | 26.75B | -0.33% | 469,020 | 20.18B |
| 64 | ROIV | Roivant Sciences Ltd. | 26.34B | 0.30% | 4,487,523 | 7.53M |
| 65 | INCY | Incyte Corporation | 26.29B | 1.36% | 1,163,950 | 5.82B |
| 66 | WST | West Pharmaceutical Services, Inc. | 24.52B | -1.37% | 383,731 | 3.33B |
| 67 | STE | STERIS plc | 23.05B | -0.60% | 906,744 | 6.04B |
| 68 | UTHR | United Therapeutics Corporation | 22.24B | 1.10% | 876,857 | 3.15B |
| 69 | GH | Guardant Health, Inc. | 22.13B | 1.07% | 1,189,450 | 1.18B |
| 70 | THC | Tenet Healthcare Corporation | 21.89B | -2.41% | 994,584 | 21.81B |
| 71 | GMAB | Genmab A/S | 20.47B | 4.06% | 2,027,505 | 4.13B |
| 72 | VTRS | Viatris Inc. | 19.20B | 1.09% | 8,331,640 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 19.12B | -0.73% | 1,272,263 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.14B | -0.96% | 247,351 | 2.78B |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 16.89B | 2.26% | 1,560,160 | 4.60B |
| 76 | ASND | Ascendis Pharma A/S | 16.61B | 0.41% | 334,043 | 1.20B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 15.72B | -0.83% | 1,471,010 | 713.07M |
| 78 | SOLV | Solventum Corporation | 15.59B | 0.39% | 1,048,011 | 8.31B |
| 79 | NBIX | Neurocrine Biosciences, Inc. | 15.59B | 0.22% | 1,042,727 | 3.37B |
| 80 | COO | The Cooper Companies, Inc. | 14.25B | -3.64% | 1,432,509 | 4.23B |
| 81 | CRL | Charles River Laboratories International, Inc. | 14.21B | -0.31% | 883,475 | 4.00B |
| 82 | EXEL | Exelixis, Inc. | 14.05B | 3.98% | 2,024,326 | 2.44B |
| 83 | RVTY | Revvity, Inc. | 13.93B | 1.50% | 1,035,679 | 2.91B |
| 84 | BAX | Baxter International Inc. | 13.59B | -0.76% | 3,792,850 | 11.47B |
| 85 | CORT | Corcept Therapeutics Incorporated | 13.36B | 0.27% | 981,684 | 830.81M |
| 86 | ICLR | ICON Public Limited Company | 13.03B | -2.63% | 445,558 | 8.29B |
| 87 | BMRN | BioMarin Pharmaceutical Inc. | 12.80B | 1.61% | 1,358,443 | 3.41B |
| 88 | PEN | Penumbra, Inc. | 12.78B | 0.19% | 271,579 | 1.50B |
| 89 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.55B | 2.48% | 981,994 | 669.50M |
| 90 | ELAN | Elanco Animal Health Incorporated | 12.54B | 2.74% | 5,311,814 | 5.02B |
| 91 | FMS | Fresenius Medical Care AG | 12.48B | -0.08% | 622,665 | 22.19B |
| 92 | HALO | Halozyme Therapeutics, Inc. | 12.41B | 0.63% | 1,598,158 | 1.66B |
| 93 | TEM | Tempus AI, Inc. | 12.40B | 3.87% | 8,879,386 | 1.43B |
| 94 | SNN | Smith & Nephew plc | 12.25B | -1.35% | 1,833,657 | 6.30B |
| 95 | BTSG | BrightSpring Health Services, Inc. | 11.92B | -3.80% | 2,601,588 | 14.37B |
| 96 | EHC | Encompass Health Corporation | 11.85B | -0.65% | 523,842 | 6.21B |
| 97 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.83B | 0.04% | 189,457 | 1.28B |
| 98 | TECH | Bio-Techne Corporation | 11.34B | -0.08% | 1,898,202 | 1.22B |
| 99 | ALGN | Align Technology, Inc. | 11.34B | -0.02% | 811,547 | 4.14B |
| 100 | DVA | DaVita Inc. | 11.34B | 0.74% | 578,479 | 14.01B |
| 101 | ABVX | ABIVAX Société Anonyme | 11.17B | 1.53% | 853,335 | 5.67M |
| 102 | GMED | Globus Medical, Inc. | 11.14B | -1.33% | 1,024,292 | 3.14B |
| 103 | CYTK | Cytokinetics, Incorporated | 10.77B | 0.48% | 1,260,831 | 67.67M |
| 104 | AXSM | Axsome Therapeutics, Inc. | 10.76B | 0.04% | 731,296 | 776.57M |
| 105 | GKOS | Glaukos Corporation | 10.69B | -2.29% | 639,663 | 612.84M |
| 106 | SMMT | Summit Therapeutics Inc. | 10.66B | 4.95% | 6,333,662 | - |
| 107 | IONS | Ionis Pharmaceuticals, Inc. | 10.56B | 2.47% | 2,435,240 | 874.09M |
| 108 | KRYS | Krystal Biotech, Inc. | 10.54B | 4.23% | 205,037 | 440.48M |
| 109 | KYMR | Kymera Therapeutics, Inc. | 10.53B | 4.62% | 930,561 | 105.00M |
| 110 | BIO | Bio-Rad Laboratories, Inc. | 10.44B | 2.25% | 295,715 | 2.59B |
| 111 | RDY | Dr. Reddy's Laboratories Limited | 10.41B | 0.98% | 1,770,475 | 3.50B |
| 112 | MOH | Molina Healthcare, Inc. | 10.40B | 0.57% | 563,068 | 42.47B |
| 113 | UHS | Universal Health Services, Inc. | 10.36B | -0.36% | 391,807 | 18.11B |
| 114 | ENSG | The Ensign Group, Inc. | 10.35B | -0.20% | 324,254 | 5.49B |
| 115 | PRAX | Praxis Precision Medicines, Inc. | 10.28B | - | 294,327 | 7.46M |
| 116 | RGEN | Repligen Corporation | 10.25B | 0.04% | 1,142,336 | 785.10M |
| 117 | APGE | Apogee Therapeutics, Inc. | 10.17B | 0.04% | 655,834 | - |
| 118 | HSIC | Henry Schein, Inc. | 9.99B | 0.16% | 819,501 | 13.60B |
| 119 | PODD | Insulet Corporation | 9.92B | -1.63% | 1,926,023 | 3.05B |
| 120 | AVTR | Avantor, Inc. | 9.75B | 1.12% | 5,555,185 | 6.56B |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.74B | -2.67% | 664,522 | 281.99M |
| 122 | OSCR | Oscar Health, Inc. | 9.54B | -2.77% | 3,384,817 | 15.32B |
| 123 | TWST | Twist Bioscience Corporation | 9.50B | 7.54% | 2,078,797 | 431.80M |
| 124 | SYRE | Spyre Therapeutics, Inc. | 9.47B | 0.67% | 923,576 | - |
| 125 | PCVX | Vaxcyte, Inc. | 9.09B | -1.26% | 1,217,876 | - |
| 126 | QGEN | Qiagen N.V. | 9.03B | 4.48% | 4,071,799 | 2.10B |
| 127 | CRNX | Crinetics Pharmaceuticals, Inc. | 9.00B | 0.09% | 1,241,640 | 42.16M |
| 128 | IMVT | Immunovant, Inc. | 8.99B | 0.42% | 1,346,677 | - |
| 129 | HQY | HealthEquity, Inc. | 8.81B | -0.01% | 616,555 | 1.34B |
| 130 | IBRX | ImmunityBio, Inc. | 8.68B | 8.05% | 11,547,392 | 165.79M |
| 131 | BRKR | Bruker Corporation | 8.66B | -0.23% | 1,626,227 | 3.50B |
| 132 | ATR | AptarGroup, Inc. | 8.57B | -0.02% | 280,914 | 3.93B |
| 133 | TXG | 10x Genomics, Inc. | 8.43B | 1.44% | 4,128,359 | 616.91M |
| 134 | ALKS | Alkermes plc | 8.26B | 0.70% | 1,127,362 | 1.67B |
| 135 | CAI | Caris Life Sciences, Inc. | 7.92B | 7.19% | 6,822,352 | 989.61M |
| 136 | TGTX | TG Therapeutics, Inc. | 7.86B | -1.05% | 1,991,544 | 799.54M |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.80B | 1.71% | 352,457 | 239.92M |
| 138 | HIMS | Hims & Hers Health, Inc. | 7.41B | 2.16% | 9,636,315 | 2.58B |
| 139 | HNGE | Hinge Health, Inc. | 7.25B | -0.12% | 2,347,825 | 720.06M |
| 140 | SRRK | Scholar Rock Holding Corporation | 7.09B | 0.09% | 1,209,500 | - |
| 141 | CHE | Chemed Corporation | 7.08B | 0.49% | 155,900 | 2.60B |
| 142 | GRFS | Grifols, S.A. | 7.04B | 1.25% | 375,055 | 8.48B |
| 143 | CGON | CG Oncology, Inc. | 7.00B | 0.92% | 736,133 | 6.23M |
| 144 | PACS | PACS Group, Inc. | 6.96B | -0.70% | 506,878 | 5.55B |
| 145 | ORKA | Oruka Therapeutics, Inc. | 6.74B | -0.59% | 1,308,015 | - |
| 146 | LNTH | Lantheus Holdings, Inc. | 6.58B | 0.07% | 837,305 | 1.56B |
| 147 | BLTE | Belite Bio, Inc | 6.51B | 1.77% | 61,849 | - |
| 148 | COGT | Cogent Biosciences, Inc. | 6.39B | 1.57% | 1,394,266 | - |
| 149 | MIRM | Mirum Pharmaceuticals, Inc. | 6.37B | 1.41% | 472,293 | 618.07M |
| 150 | TVTX | Travere Therapeutics, Inc. | 6.32B | 2.74% | 1,507,369 | 591.33M |
| 151 | LQDA | Liquidia Corporation | 6.31B | 0.31% | 931,033 | 450.91M |
| 152 | DNTH | Dianthus Therapeutics, Inc. | 6.27B | 1.85% | 552,011 | 1.90M |
| 153 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.26B | 1.03% | 401,969 | 840.85M |
| 154 | AMRX | Amneal Pharmaceuticals, Inc. | 6.24B | 0.79% | 1,141,341 | 3.12B |
| 155 | ERAS | Erasca, Inc. | 6.21B | 0.91% | 2,663,082 | - |
| 156 | STVN | Stevanato Group S.p.A. | 6.20B | 1.93% | 204,595 | 1.40B |
| 157 | BLCO | Bausch + Lomb Corporation | 6.16B | -0.40% | 476,331 | 5.32B |
| 158 | PTCT | PTC Therapeutics, Inc. | 6.13B | 3.39% | 624,462 | 1.01B |
| 159 | RDNT | RadNet, Inc. | 6.05B | 2.91% | 444,821 | 2.27B |
| 160 | DFTX | Definium Therapeutics, Inc. | 6.02B | 3.56% | 1,271,048 | - |
| 161 | TFX | Teleflex Incorporated | 5.94B | 1.35% | 382,406 | 2.25B |
| 162 | CRSP | CRISPR Therapeutics AG | 5.89B | 6.69% | 2,083,554 | 13.39M |
| 163 | XENE | Xenon Pharmaceuticals Inc. | 5.85B | -0.23% | 418,012 | 7.50M |
| 164 | LGND | Ligand Pharmaceuticals Incorporated | 5.62B | 0.55% | 209,400 | 290.54M |
| 165 | SHC | Sotera Health Company | 5.57B | 1.77% | 1,759,469 | 1.22B |
| 166 | MMSI | Merit Medical Systems, Inc. | 5.44B | 0.90% | 711,665 | 1.58B |
| 167 | MMED | MiniMed Group, Inc. | 5.31B | -5.12% | 1,102,408 | 3.10B |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.27B | 3.10% | 1,523,784 | 1.14B |
| 169 | HAE | Haemonetics Corporation | 4.93B | -0.07% | 502,182 | 1.35B |
| 170 | DYN | Dyne Therapeutics, Inc. | 4.92B | 1.35% | 1,459,196 | - |
| 171 | PBLS | Parabilis Medicines, Inc. | 4.85B | 2.08% | 286,021 | 148.00K |
| 172 | EWTX | Edgewise Therapeutics, Inc. | 4.80B | -1.14% | 1,149,210 | - |
| 173 | BLLN | BillionToOne, Inc. | 4.72B | 3.45% | 902,929 | 397.41M |
| 174 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.70B | -1.81% | 2,147,376 | -665.00K |
| 175 | LFST | LifeStance Health Group, Inc. | 4.69B | 0.99% | 3,623,937 | 1.58B |
| 176 | WAY | Waystar Holding Corp. | 4.64B | -4.50% | 4,935,827 | 1.21B |
| 177 | ICUI | ICU Medical, Inc. | 4.56B | -0.17% | 130,351 | 2.16B |
| 178 | CELC | Celcuity Inc. | 4.51B | 1.63% | 603,694 | - |
| 179 | RLAY | Relay Therapeutics, Inc. | 4.51B | 4.10% | 2,761,581 | 10.35M |
| 180 | ELVN | Enliven Therapeutics, Inc. | 4.47B | -0.23% | 804,350 | - |
| 181 | CON | Concentra Group Holdings Parent, Inc. | 4.44B | -0.60% | 632,301 | 2.29B |
| 182 | NVST | Envista Holdings Corporation | 4.41B | 0.48% | 2,544,153 | 2.86B |
| 183 | DOCS | Doximity, Inc. | 4.41B | -2.21% | 1,727,541 | 655.57M |
| 184 | LIVN | LivaNova PLC | 4.37B | 1.47% | 562,918 | 1.47B |
| 185 | HTFL | HeartFlow, Inc. | 4.34B | -0.62% | 1,749,035 | 212.07M |
| 186 | MANE | Veradermics, Incorporated | 4.28B | 3.95% | 787,162 | - |
| 187 | ITGR | Integer Holdings Corporation | 4.26B | 0.26% | 681,853 | 1.84B |
| 188 | INDV | Indivior Pharmaceuticals, Inc. | 4.24B | -0.58% | 1,717,699 | 1.33B |
| 189 | ADPT | Adaptive Biotechnologies Corporation | 4.19B | 2.74% | 1,221,773 | 308.08M |
| 190 | TNGX | Tango Therapeutics, Inc. | 4.18B | 1.06% | 2,283,192 | 53.81M |
| 191 | LEGN | Legend Biotech Corporation | 4.13B | 1.72% | 1,408,246 | 1.27B |
| 192 | IDYA | IDEAYA Biosciences, Inc. | 4.10B | 6.09% | 1,022,213 | 234.13M |
| 193 | IRTC | iRhythm Holdings, Inc. | 4.06B | -1.72% | 353,484 | 825.34M |
| 194 | ABCL | AbCellera Biologics Inc. | 4.05B | 17.81% | 10,699,282 | 66.17M |
| 195 | RCUS | Arcus Biosciences, Inc. | 4.02B | 4.81% | 655,704 | 117.00M |
| 196 | VKTX | Viking Therapeutics, Inc. | 3.99B | 2.83% | 2,095,851 | - |
| 197 | DNLI | Denali Therapeutics Inc. | 3.98B | 3.02% | 1,120,452 | 3.60M |
| 198 | TLX | Telix Pharmaceuticals Limited | 3.93B | 0.09% | 95,740 | 890.79M |
| 199 | IOVA | Iovance Biotherapeutics, Inc. | 3.82B | 4.71% | 11,907,843 | 324.97M |
| 200 | GRAL | GRAIL, Inc. | 3.69B | 7.78% | 658,559 | 165.26M |
| 201 | OGN | Organon & Co. | 3.61B | - | 3,562,736 | 6.13B |
| 202 | GPCR | Structure Therapeutics Inc. | 3.56B | 1.86% | 463,838 | - |
| 203 | QURE | uniQure N.V. | 3.54B | 7.56% | 2,189,704 | 18.67M |
| 204 | OPCH | Option Care Health, Inc. | 3.54B | -0.13% | 2,389,563 | 5.69B |
| 205 | VCYT | Veracyte, Inc. | 3.54B | 6.20% | 1,155,346 | 561.90M |
| 206 | NHC | National HealthCare Corporation | 3.52B | -1.60% | 94,146 | 1.56B |
| 207 | PLSE | Pulse Biosciences, Inc. | 3.49B | -0.26% | 366,612 | 1.19M |
| 208 | IMNM | Immunome, Inc. | 3.34B | 4.91% | 1,928,721 | 4.02M |
| 209 | MBX | MBX Biosciences, Inc. | 3.30B | 3.36% | 273,986 | - |
| 210 | NAMS | NewAmsterdam Pharma Company N.V. | 3.27B | 1.82% | 1,986,351 | 7.12M |
| 211 | TMDX | TransMedics Group, Inc. | 3.25B | - | 405,067 | 668.47M |
| 212 | CLDX | Celldex Therapeutics, Inc. | 3.24B | 1.60% | 550,917 | 158.00K |
| 213 | WRBY | Warby Parker Inc. | 3.21B | -0.80% | 1,916,354 | 911.61M |
| 214 | IRON | Disc Medicine, Inc. | 3.16B | 1.82% | 320,943 | - |
| 215 | TARS | Tarsus Pharmaceuticals, Inc. | 3.14B | -1.87% | 538,346 | 606.33M |
| 216 | ARQT | Arcutis Biotherapeutics, Inc. | 3.12B | 0.32% | 1,185,593 | 463.98M |
| 217 | ALMS | Alumis Inc. | 3.10B | 4.04% | 587,249 | 7.40M |
| 218 | BEAM | Beam Therapeutics Inc. | 3.10B | 9.53% | 2,188,309 | 156.04M |
| 219 | AVAH | Aveanna Healthcare Holdings Inc. | 2.97B | -0.80% | 2,900,144 | 2.60B |
| 220 | ZLAB | Zai Lab Limited | 2.94B | 2.07% | 705,450 | 449.61M |
| 221 | BKD | Brookdale Senior Living Inc. | 2.91B | 0.66% | 5,183,339 | 2.93B |
| 222 | SLS | SELLAS Life Sciences Group, Inc. | 2.85B | -1.67% | 8,205,530 | - |
| 223 | ALHC | Alignment Healthcare, Inc. | 2.82B | 1.19% | 3,730,838 | 4.58B |
| 224 | NRIX | Nurix Therapeutics, Inc. | 2.80B | 2.59% | 1,176,297 | 36.77M |
| 225 | ACHC | Acadia Healthcare Company, Inc. | 2.78B | 4.00% | 1,910,958 | 3.37B |
| 226 | ATAI | AtaiBeckley Inc. | 2.76B | 0.81% | 9,687,089 | 4.47M |
| 227 | RGC | Regencell Bioscience Holdings Limited | 2.74B | 4.73% | 79,253 | - |
| 228 | VRDN | Viridian Therapeutics, Inc. | 2.74B | 0.67% | 901,372 | 71.13M |
| 229 | PRVA | Privia Health Group, Inc. | 2.71B | 0.86% | 983,968 | 2.36B |
| 230 | AXGN | Axogen, Inc. | 2.68B | 1.42% | 537,164 | 251.17M |
| 231 | SUPN | Supernus Pharmaceuticals, Inc. | 2.64B | 0.55% | 496,055 | 830.44M |
| 232 | CDNA | CareDx, Inc. | 2.63B | 6.95% | 1,787,822 | 458.09M |
| 233 | GENB | Generate Biomedicines, Inc. | 2.62B | 15.01% | 4,691,298 | 26.48M |
| 234 | PHVS | Pharvaris N.V. | 2.61B | -0.21% | 861,164 | - |
| 235 | WGS | GeneDx Holdings Corp. | 2.61B | 2.60% | 682,906 | 454.43M |
| 236 | PGEN | Precigen, Inc. | 2.61B | 1.53% | 5,842,035 | 85.72M |
| 237 | RARE | Ultragenyx Pharmaceutical Inc. | 2.60B | 2.88% | 3,807,810 | 717.00M |
| 238 | NKTR | Nektar Therapeutics | 2.56B | 1.72% | 414,905 | 54.59M |
| 239 | TRVI | Trevi Therapeutics, Inc. | 2.56B | -0.72% | 2,141,450 | - |
| 240 | VERA | Vera Therapeutics, Inc. | 2.54B | 4.63% | 2,489,639 | - |
| 241 | NEOG | Neogen Corporation | 2.54B | 0.34% | 1,047,807 | 870.40M |
| 242 | BHC | Bausch Health Companies Inc. | 2.52B | 0.75% | 3,455,753 | 10.85B |
| 243 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.51B | 1.55% | 2,332,555 | 940.61M |
| 244 | NUVB | Nuvation Bio Inc. | 2.49B | 5.03% | 4,154,729 | 169.90M |
| 245 | ATRC | AtriCure, Inc. | 2.48B | -1.22% | 966,666 | 569.62M |
| 246 | KOD | Kodiak Sciences Inc. | 2.48B | 6.02% | 571,078 | - |
| 247 | RAPP | Rapport Therapeutics, Inc. | 2.46B | 3.73% | 324,470 | 20.00M |
| 248 | PBH | Prestige Consumer Healthcare Inc. | 2.44B | -1.10% | 368,847 | 1.10B |
| 249 | BFLY | Butterfly Network, Inc. | 2.41B | 1.01% | 4,038,900 | 112.14M |
| 250 | OCUL | Ocular Therapeutix, Inc. | 2.39B | 0.93% | 1,842,282 | 52.06M |
| 251 | GRDN | Guardian Pharmacy Services, Inc. | 2.36B | -1.06% | 321,614 | 1.46B |
| 252 | UFPT | UFP Technologies, Inc. | 2.36B | -0.39% | 104,903 | 631.64M |
| 253 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.34B | 6.76% | 5,697,283 | 208.78M |
| 254 | MLYS | Mineralys Therapeutics, Inc. | 2.33B | 4.23% | 863,959 | - |
| 255 | COAG | Hemab Therapeutics Holdings, Inc. | 2.32B | 6.39% | 527,131 | - |
| 256 | KLRA | Kailera Therapeutics, Inc. | 2.30B | 7.32% | 1,323,871 | - |
| 257 | ALMR | Alamar Biosciences, Inc. | 2.29B | 0.98% | 327,769 | 100.42M |
| 258 | HRMY | Harmony Biosciences Holdings, Inc. | 2.27B | 1.17% | 375,521 | 959.90M |
| 259 | URGN | UroGen Pharma Ltd. | 2.27B | 0.43% | 570,155 | 188.73M |
| 260 | AUPH | Aurinia Pharmaceuticals Inc. | 2.23B | 1.09% | 780,569 | 311.51M |
| 261 | ADUS | Addus HomeCare Corporation | 2.22B | 0.22% | 151,994 | 1.48B |
| 262 | VCEL | Vericel Corporation | 2.21B | 2.17% | 465,741 | 306.30M |
| 263 | ZBIO | Zenas BioPharma, Inc. | 2.20B | 6.70% | 633,522 | 1.00M |
| 264 | MESO | Mesoblast Limited | 2.19B | 3.31% | 148,037 | 65.38M |
| 265 | CLOV | Clover Health Investments, Corp. | 2.19B | 0.49% | 2,706,846 | 2.48B |
| 266 | XRAY | DENTSPLY SIRONA Inc. | 2.19B | 0.73% | 3,106,779 | 3.64B |
| 267 | TRLV | Trulieve Cannabis Corp. | 2.18B | 1.62% | 1,470,254 | 1.14B |
| 268 | XNCR | Xencor, Inc. | 2.18B | 1.03% | 1,566,748 | 104.97M |
| 269 | ADMA | ADMA Biologics, Inc. | 2.18B | 1.78% | 1,479,006 | 512.28M |
| 270 | BHVN | Biohaven Ltd. | 2.17B | 5.12% | 3,441,597 | - |
| 271 | STOK | Stoke Therapeutics, Inc. | 2.16B | 3.53% | 728,620 | 27.59M |
| 272 | NEO | NeoGenomics, Inc. | 2.16B | 2.32% | 872,086 | 766.30M |
| 273 | ESTA | Establishment Labs Holdings Inc. | 2.15B | 0.12% | 407,844 | 245.82M |
| 274 | MD | Pediatrix Medical Group, Inc. | 2.14B | 1.47% | 507,704 | 1.95B |
| 275 | PVLA | Palvella Therapeutics, Inc. | 2.14B | 1.71% | 191,987 | - |
| 276 | HCM | HUTCHMED (China) Limited | 2.12B | 0.66% | 73,558 | 549.12M |
| 277 | NBTX | Nanobiotix S.A. | 2.12B | 4.66% | 177,918 | 38.27M |
| 278 | CMPS | COMPASS Pathways plc | 2.06B | 4.79% | 2,284,231 | - |
| 279 | NVCR | NovoCure Limited | 2.05B | 5.13% | 902,906 | 699.19M |
| 280 | AGIO | Agios Pharmaceuticals, Inc. | 2.02B | 3.86% | 742,173 | 98.34M |
| 281 | TSHA | Taysha Gene Therapies, Inc. | 2.02B | 3.85% | 1,690,609 | 5.49M |
| 282 | PRGO | Perrigo Company plc | 2.01B | 1.47% | 3,167,358 | 4.14B |
| 283 | SRPT | Sarepta Therapeutics, Inc. | 2.00B | 4.36% | 1,696,408 | 1.97B |
| 284 | GHRS | GH Research PLC | 1.99B | 2.92% | 113,208 | - |
| 285 | PGNY | Progyny, Inc. | 1.98B | 1.45% | 1,405,945 | 1.31B |
| 286 | KARD | Kardigan, Inc. | 1.96B | 1.36% | 229,953 | - |
| 287 | ZYME | Zymeworks Inc. | 1.95B | -4.52% | 2,076,578 | 37.13M |
| 288 | SNDA | Sonida Senior Living, Inc. | 1.94B | 4.04% | 631,501 | 481.07M |
| 289 | FBRX | Forte Biosciences, Inc. | 1.94B | 0.03% | 1,235,741 | - |
| 290 | LKFT | Lakefront Biotherapeutics NV | 1.93B | 2.27% | 333,258 | 1.13B |
| 291 | SEPN | Septerna, Inc. | 1.93B | 1.92% | 333,357 | 98.88M |
| 292 | IMCR | Immunocore Holdings plc | 1.93B | 2.16% | 257,337 | 430.78M |
| 293 | ASTH | Astrana Health, Inc. | 1.92B | -1.31% | 362,720 | 3.84B |
| 294 | RXRX | Recursion Pharmaceuticals, Inc. | 1.91B | 9.54% | 22,516,635 | 54.86M |
| 295 | NTLA | Intellia Therapeutics, Inc. | 1.89B | 7.56% | 4,091,524 | 59.51M |
| 296 | DMRA | Damora Therapeutics, Inc. | 1.89B | 1.02% | 205,708 | - |
| 297 | PSNL | Personalis, Inc. | 1.84B | 1.11% | 2,897,036 | 69.67M |
| 298 | SGRY | Surgery Partners, Inc. | 1.82B | 0.72% | 2,274,250 | 3.37B |
| 299 | BLFS | BioLife Solutions, Inc. | 1.82B | 0.08% | 1,377,721 | 106.69M |
| 300 | VIR | Vir Biotechnology, Inc. | 1.81B | 8.07% | 2,961,369 | 303.23M |
| 301 | INBX | Inhibrx Biosciences, Inc. | 1.81B | 16.94% | 510,558 | 1.30M |
| 302 | LMAT | LeMaitre Vascular, Inc. | 1.81B | -1.24% | 447,662 | 262.43M |
| 303 | ALVO | Alvotech | 1.80B | -3.81% | 1,771,909 | 494.61M |
| 304 | ETON | Eton Pharmaceuticals, Inc. | 1.80B | -2.14% | 536,951 | 105.60M |
| 305 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | 1.79% | 974,943 | 252.25M |
| 306 | BRVE | Braveheart Bio, Inc. | 1.77B | 0.51% | 155,334 | - |
| 307 | INSP | Inspire Medical Systems, Inc. | 1.77B | -0.65% | 524,819 | 898.74M |
| 308 | FTRE | Fortrea Holdings Inc. | 1.74B | -0.22% | 599,460 | 2.68B |
| 309 | ANAB | AnaptysBio, Inc. | 1.73B | -0.12% | 341,833 | 232.39M |
| 310 | AVLN | Avalyn Pharma Inc. | 1.69B | 1.35% | 108,362 | - |
| 311 | MAZE | Maze Therapeutics, Inc. | 1.69B | 2.77% | 307,641 | 20.00M |
| 312 | ABSI | Absci Corporation | 1.65B | 8.94% | 2,339,877 | 1.56M |
| 313 | BCAX | Bicara Therapeutics Inc. | 1.63B | 4.24% | 410,308 | - |
| 314 | ANIP | ANI Pharmaceuticals, Inc. | 1.62B | 2.00% | 811,882 | 978.38M |
| 315 | AGL | agilon health, inc. | 1.61B | 2.47% | 183,985 | 5.92B |
| 316 | TRAX | First Tracks Biotherapeutics, Inc. | 1.61B | 4.23% | 441,583 | - |
| 317 | ARDT | Ardent Health, Inc. | 1.59B | 0.44% | 364,102 | 6.41B |
| 318 | XERS | Xeris Biopharma Holdings, Inc. | 1.59B | - | 1,005,619 | 335.41M |
| 319 | TYRA | Tyra Biosciences, Inc. | 1.59B | 2.30% | 317,813 | - |
| 320 | KMTS | Kestra Medical Technologies, Ltd. | 1.58B | 0.04% | 159,553 | 95.13M |
| 321 | HCSG | Healthcare Services Group, Inc. | 1.57B | 0.61% | 406,615 | 1.86B |
| 322 | LBRX | LB Pharmaceuticals Inc | 1.57B | 1.22% | 217,010 | - |
| 323 | AAPG | Ascentage Pharma Group International | 1.56B | 0.48% | 3,354 | 94.61M |
| 324 | NVAX | Novavax, Inc. | 1.56B | 6.55% | 7,107,634 | 413.80M |
| 325 | HROW | Harrow, Inc. | 1.55B | 3.84% | 472,269 | 275.59M |
| 326 | AVBP | ArriVent BioPharma, Inc. | 1.55B | 10.93% | 961,652 | - |
| 327 | CNMD | CONMED Corporation | 1.53B | -0.70% | 296,729 | 1.37B |
| 328 | INVA | Innoviva, Inc. | 1.53B | 0.67% | 412,673 | 440.00M |
| 329 | APMD | Apnimed, Inc. | 1.52B | 6.79% | 480,631 | 120.15M |
| 330 | OMCL | Omnicell, Inc. | 1.52B | -4.15% | 667,014 | 1.25B |
| 331 | SLBT | SL Science Holding Limited | 1.51B | -2.58% | 58,859 | 3.27M |
| 332 | FRNM | Freenome, Inc. | 1.50B | 1.52% | 475,975 | 35.41M |
| 333 | TNDM | Tandem Diabetes Care, Inc. | 1.50B | -2.88% | 1,186,486 | 1.04B |
| 334 | SDGR | Schrödinger, Inc. | 1.50B | 6.50% | 899,851 | 259.04M |
| 335 | REPL | Replimune Group, Inc. | 1.49B | 7.41% | 3,136,911 | - |
| 336 | AKTS | Aktis Oncology, Inc. | 1.48B | 2.73% | 601,207 | 10.06M |
| 337 | INNV | InnovAge Holding Corp. | 1.48B | -0.91% | 149,458 | 949.17M |
| 338 | CGEM | Cullinan Therapeutics, Inc. | 1.48B | 5.18% | 519,204 | - |
| 339 | ENOV | Enovis Corporation | 1.48B | 1.47% | 565,204 | 2.30B |
| 340 | OMDA | Omada Health, Inc. | 1.47B | -0.58% | 653,192 | 309.76M |
| 341 | PAHC | Phibro Animal Health Corporation | 1.46B | 1.76% | 236,800 | 1.50B |
| 342 | AZTA | Azenta, Inc. | 1.45B | 1.00% | 988,847 | 613.81M |
| 343 | ATEC | Alphatec Holdings, Inc. | 1.44B | 0.97% | 1,582,872 | 815.05M |
| 344 | ORIC | ORIC Pharmaceuticals, Inc. | 1.43B | 2.75% | 1,168,709 | - |
| 345 | MGTX | MeiraGTx Holdings plc | 1.43B | 0.61% | 689,525 | 397.50M |
| 346 | LTGO | Latigo Biotherapeutics, Inc. | 1.43B | 2.59% | 142,843 | - |
| 347 | ANRO | Alto Neuroscience, Inc. | 1.42B | 0.17% | 474,189 | - |
| 348 | SVRA | Savara Inc. | 1.42B | 0.72% | 1,608,464 | - |
| 349 | VOR | Vor Biopharma Inc. | 1.42B | 5.72% | 1,219,908 | - |
| 350 | OMER | Omeros Corporation | 1.40B | -0.21% | 1,315,455 | 38.42M |
| 351 | JBIO | Jade Biosciences, Inc. | 1.39B | 2.39% | 603,529 | - |
| 352 | DRTS | Alpha Tau Medical Ltd. | 1.36B | - | 494,957 | - |
| 353 | MNKD | MannKind Corporation | 1.34B | 2.21% | 3,193,654 | 393.63M |
| 354 | PNTG | The Pennant Group, Inc. | 1.34B | -1.65% | 226,216 | 1.10B |
| 355 | SPTX | Seaport Therapeutics, Inc. | 1.33B | 3.11% | 85,780 | - |
| 356 | MLTX | MoonLake Immunotherapeutics | 1.32B | 1.24% | 819,122 | - |
| 357 | AMN | AMN Healthcare Services, Inc. | 1.31B | -1.74% | 486,132 | 3.43B |
| 358 | IART | Integra LifeSciences Holdings Corporation | 1.31B | 0.60% | 369,534 | 1.65B |
| 359 | CRON | Cronos Group Inc. | 1.29B | 2.93% | 2,464,135 | 179.09M |
| 360 | NUTX | Nutex Health Inc. | 1.29B | 0.27% | 177,347 | 846.72M |
| 361 | AORT | Artivion, Inc. | 1.29B | -1.90% | 735,677 | 471.47M |
| 362 | IMTX | Immatics N.V. | 1.26B | 6.33% | 1,062,765 | 47.65M |
| 363 | ODTX | Odyssey Therapeutics, Inc. | 1.26B | 4.14% | 163,700 | 99.00K |
| 364 | GLUE | Monte Rosa Therapeutics, Inc. | 1.24B | 5.66% | 1,098,756 | 28.73M |
| 365 | CERT | Certara, Inc. | 1.24B | 2.26% | 2,558,913 | 421.75M |
| 366 | PRCT | PROCEPT BioRobotics Corporation | 1.24B | 1.65% | 595,350 | 337.34M |
| 367 | SANA | Sana Biotechnology, Inc. | 1.23B | 8.47% | 3,001,396 | - |
| 368 | CRVS | Corvus Pharmaceuticals, Inc. | 1.22B | 3.34% | 642,255 | - |
| 369 | KURA | Kura Oncology, Inc. | 1.21B | 9.60% | 5,382,449 | 77.23M |
| 370 | GDRX | GoodRx Holdings, Inc. | 1.19B | 1.02% | 1,036,554 | 785.23M |
| 371 | BVS | Bioventus Inc. | 1.18B | 0.43% | 584,495 | 581.85M |
| 372 | STAA | STAAR Surgical Company | 1.16B | -0.34% | 523,007 | 339.59M |
| 373 | LMRI | Lumexa Imaging Holdings, Inc. | 1.16B | 1.86% | 344,946 | 1.04B |
| 374 | USPH | U.S. Physical Therapy, Inc. | 1.15B | -0.08% | 152,126 | 804.27M |
| 375 | JANX | Janux Therapeutics, Inc. | 1.14B | 0.43% | 1,074,338 | 24.00M |
| 376 | IVA | Inventiva S.A. | 1.13B | - | 381,242 | 7.94M |
| 377 | TDOC | Teladoc Health, Inc. | 1.12B | -0.16% | 3,265,386 | 2.49B |
| 378 | IRMD | IRADIMED CORPORATION | 1.12B | 0.79% | 88,003 | 86.34M |
| 379 | OPK | OPKO Health, Inc. | 1.11B | 0.68% | 2,243,317 | 587.90M |
| 380 | CSTL | Castle Biosciences, Inc. | 1.07B | 4.57% | 483,359 | 357.28M |
| 381 | SLDB | Solid Biosciences Inc. | 1.06B | 7.97% | 1,260,520 | - |
| 382 | AVTX | Avalo Therapeutics, Inc. | 1.06B | 2.44% | 1,015,404 | 59.00K |
| 383 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.04B | 0.86% | 1,821,248 | 41.47M |
| 384 | CADL | Candel Therapeutics, Inc. | 1.04B | 5.75% | 1,342,864 | - |
| 385 | IMMX | Immix Biopharma, Inc. | 1.04B | 6.32% | 3,660,739 | - |
| 386 | WVE | Wave Life Sciences, Inc. | 1.03B | 2.54% | 2,413,871 | 65.37M |
| 387 | QDEL | QuidelOrtho Corporation | 1.03B | 3.86% | 987,349 | 2.67B |
| 388 | ABUS | Arbutus Biopharma Corporation | 1.03B | - | 8,912,914 | 181.72M |
| 389 | CLYM | Climb Bio, Inc. | 1.02B | 8.78% | 1,204,163 | - |
| 390 | HELP | Cybin Inc. | 1.02B | 7.41% | 3,006,123 | - |
| 391 | PCRX | Pacira BioSciences, Inc. | 1.02B | 2.70% | 379,713 | 746.16M |
| 392 | GERN | Geron Corporation | 995.83M | 1.97% | 9,843,888 | 204.56M |
| 393 | GMRS | GMR Solutions Inc. | 987.07M | -4.08% | 358,697 | 5.88B |
| 394 | DSGN | Design Therapeutics, Inc. | 981.28M | 2.95% | 608,065 | - |
| 395 | ANNX | Annexon, Inc. | 976.33M | 1.78% | 2,941,736 | - |
| 396 | ACRS | Aclaris Therapeutics, Inc. | 961.94M | 3.57% | 3,353,214 | 8.22M |
| 397 | GLAS | Glass House Brands Inc. | 954.68M | 2.53% | 318,590 | 176.98M |
| 398 | OLMA | Olema Pharmaceuticals, Inc. | 954.60M | 4.60% | 799,923 | - |
| 399 | ARDX | Ardelyx, Inc. | 941.93M | 1.07% | 3,428,416 | 450.89M |
| 400 | AMPH | Amphastar Pharmaceuticals, Inc. | 934.98M | 2.14% | 283,723 | 730.02M |
| 401 | CBLL | CeriBell, Inc. | 919.16M | 0.04% | 243,255 | 101.96M |
| 402 | COLL | Collegium Pharmaceutical, Inc. | 894.30M | 0.44% | 534,566 | 808.21M |
| 403 | FTH | Faeth Therapeutics, Inc. | 892.01M | -0.55% | 365,140 | - |
| 404 | SGP | SpyGlass Pharma, Inc. | 889.72M | 1.29% | 60,332 | - |
| 405 | ANL | Adlai Nortye Ltd. | 884.83M | -2.97% | 100,195 | 18.06M |
| 406 | TBPH | Theravance Biopharma, Inc. | 884.18M | 0.12% | 332,379 | 104.31M |
| 407 | SIBN | SI-BONE, Inc. | 875.75M | 0.36% | 557,774 | 213.60M |
| 408 | DBVT | DBV Technologies S.A. | 873.69M | 5.87% | 154,928 | 5.04M |
| 409 | RIGL | Rigel Pharmaceuticals, Inc. | 873.28M | 3.64% | 373,872 | 276.79M |
| 410 | BBNX | Beta Bionics, Inc. | 870.10M | -1.98% | 710,955 | 119.01M |
| 411 | FDMT | 4D Molecular Therapeutics, Inc. | 868.44M | 2.14% | 919,087 | 92.01M |
| 412 | AVR | Anteris Technologies Global Corp. | 866.41M | 1.02% | 515,281 | 2.24M |
| 413 | INMD | InMode Ltd. | 863.94M | -0.46% | 298,681 | 374.63M |
| 414 | HSTM | HealthStream, Inc. | 844.16M | 0.31% | 135,250 | 321.12M |
| 415 | NVCT | Nuvectis Pharma, Inc. | 843.54M | 8.46% | 276,624 | - |
| 416 | AHG | Akso Health Group | 843.18M | 4.36% | 6,813 | 13.83M |
| 417 | ACHV | Achieve Life Sciences, Inc. | 840.71M | 2.90% | 1,323,847 | - |
| 418 | ATTO | Attovia Therapeutics, Inc. | 830.89M | -6.35% | 189,232 | 1.35M |
| 419 | PHAR | Pharming Group N.V. | 830.52M | 2.71% | 21,512 | 366.48M |
| 420 | OBX | Obsidian Therapeutics, Inc. | 823.20M | 1.60% | 155,705 | - |
| 421 | SLN | Silence Therapeutics plc | 823.06M | 2.86% | 645,030 | 615.00K |
| 422 | NGNE | Neurogene Inc. | 817.26M | 3.03% | 504,318 | 925.00K |
| 423 | AURA | Aura Biosciences, Inc. | 810.97M | -1.01% | 1,131,945 | - |
| 424 | STTK | Shattuck Labs, Inc. | 808.93M | 2.03% | 869,797 | 1.00M |
| 425 | OCS | Oculis Holding AG | 800.05M | -1.67% | 192,366 | 1.45M |
| 426 | DRUG | Bright Minds Biosciences Inc. | 782.27M | 3.19% | 159,563 | - |
| 427 | VREX | Varex Imaging Corporation | 779.74M | -0.11% | 493,361 | 865.00M |
| 428 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 751.23M | 2.52% | 197,974 | - |
| 429 | ALLO | Allogene Therapeutics, Inc. | 749.72M | 6.90% | 6,156,769 | 4.64M |
| 430 | MNPR | Monopar Therapeutics Inc. | 743.84M | -0.48% | 133,183 | - |
| 431 | TECX | Tectonic Therapeutic, Inc. | 737.21M | 3.40% | 144,457 | - |
| 432 | SOPH | SOPHiA GENETICS SA | 736.36M | 2.37% | 798,609 | 86.17M |
| 433 | CTMX | CytomX Therapeutics, Inc. | 734.32M | 2.43% | 4,027,234 | 18.30M |
| 434 | AHCO | AdaptHealth Corp. | 731.08M | -2.66% | 4,082,730 | 3.36B |
| 435 | CBIO | Crescent Biopharma, Inc. | 727.62M | 0.18% | 129,672 | 11.88M |
| 436 | IRWD | Ironwood Pharmaceuticals, Inc. | 725.40M | 6.30% | 1,848,932 | 389.32M |
| 437 | ASMB | Assembly Biosciences, Inc. | 719.34M | 0.14% | 553,778 | 74.85M |
| 438 | ZVRA | Zevra Therapeutics, Inc. | 714.98M | 3.35% | 820,558 | 136.07M |
| 439 | PHR | Phreesia, Inc. | 712.07M | -1.45% | 664,671 | 495.59M |
| 440 | SSII | SS Innovations International, Inc. | 711.37M | 1.43% | 40,326 | 52.40M |
| 441 | GYRE | Gyre Therapeutics, Inc. | 708.31M | 3.73% | 44,531 | 109.82M |
| 442 | PHAT | Phathom Pharmaceuticals, Inc. | 698.98M | 1.62% | 748,466 | 239.66M |
| 443 | MPLT | MapLight Therapeutics, Inc. | 696.92M | 10.39% | 703,442 | - |
| 444 | AGMB | AgomAb Therapeutics NV | 690.46M | 9.36% | 219,272 | - |
| 445 | EIKN | Eikon Therapeutics, Inc. | 679.77M | 12.46% | 567,202 | - |
| 446 | PRLD | Prelude Therapeutics Incorporated | 678.74M | 1.85% | 415,360 | 22.42M |
| 447 | OABI | OmniAb, Inc. | 677.52M | -1.06% | 1,467,053 | 38.46M |
| 448 | EVO | Evotec SE | 674.99M | - | 25,267 | 819.47M |
| 449 | CRMD | CorMedix Inc. | 667.20M | 3.38% | 1,235,615 | 462.25M |
| 450 | TLRY | Tilray Brands, Inc. | 661.80M | 3.39% | 3,494,649 | 915.45M |
| 451 | PRME | Prime Medicine, Inc. | 660.02M | 14.15% | 3,320,951 | 4.07M |
| 452 | ANGO | AngioDynamics, Inc. | 659.25M | 1.08% | 280,389 | 320.17M |
| 453 | AUTL | Autolus Therapeutics plc | 649.44M | 4.27% | 1,521,394 | 117.39M |
| 454 | STLN | Starling Oncology, Inc. | 642.07M | 2.77% | 1,020,971 | 587.24M |
| 455 | CTNM | Contineum Therapeutics, Inc. | 641.44M | 2.53% | 724,748 | - |
| 456 | VSTM | Verastem, Inc. | 641.19M | 3.21% | 1,190,306 | 87.53M |
| 457 | VALN | Valneva SE | 640.49M | 0.44% | 30,970 | 163.30M |
| 458 | KIDS | OrthoPediatrics Corp. | 639.69M | -2.35% | 188,049 | 252.72M |
| 459 | SGMT | Sagimet Biosciences Inc. | 639.61M | 0.78% | 968,555 | - |
| 460 | CTEV | Claritev Corporation | 637.90M | 2.90% | 139,859 | 994.67M |
| 461 | AQST | Aquestive Therapeutics, Inc. | 637.60M | 5.83% | 3,668,574 | 54.09M |
| 462 | MDXG | MiMedx Group, Inc. | 632.60M | 1.64% | 700,020 | 355.17M |
| 463 | ARVN | Arvinas, Inc. | 627.71M | 2.78% | 530,591 | 316.70M |
| 464 | ALT | Altimmune, Inc. | 622.46M | 2.89% | 3,819,791 | 31.00K |
| 465 | ZURA | Zura Bio Limited | 605.64M | 0.32% | 2,822,034 | - |
| 466 | ENTX | Entera Bio Ltd. | 600.80M | 1.46% | 429,944 | 42.00K |
| 467 | CTKB | Cytek Biosciences, Inc. | 595.32M | 3.15% | 604,985 | 206.71M |
| 468 | EOLS | Evolus, Inc. | 592.80M | 2.22% | 1,796,671 | 316.49M |
| 469 | SCTX | Scribe Therapeutics Inc. | 588.66M | -16.23% | 315,999 | 36.28M |
| 470 | RGNX | REGENXBIO Inc. | 588.18M | 10.55% | 1,756,724 | 174.48M |
| 471 | DCTH | Delcath Systems, Inc. | 587.10M | 1.01% | 503,691 | 95.42M |
| 472 | BWAY | BrainsWay Ltd. | 583.55M | 1.69% | 56,537 | 60.70M |
| 473 | WEAV | Weave Communications, Inc. | 583.19M | - | 4,271,364 | 257.79M |
| 474 | ARTV | Artiva Biotherapeutics, Inc. | 575.44M | 2.17% | 266,349 | 251.00K |
| 475 | SPRY | ARS Pharmaceuticals, Inc. | 568.84M | 6.92% | 1,715,833 | 116.93M |
| 476 | OVID | Ovid Therapeutics Inc. | 568.32M | 3.19% | 1,449,515 | 1.58M |
| 477 | BLSM | BlossomHill Therapeutics, Inc. | 564.46M | 14.91% | 193,519 | - |
| 478 | EVH | Evolent Health, Inc. | 552.86M | 3.60% | 2,872,690 | 2.10B |
| 479 | FLGT | Fulgent Genetics, Inc. | 548.93M | 2.57% | 185,306 | 323.93M |
| 480 | CERS | Cerus Corporation | 548.15M | 1.12% | 831,125 | 221.55M |
| 481 | SRTA | Strata Critical Medical, Inc. | 547.61M | 3.69% | 906,566 | 255.98M |
| 482 | KYTX | Kyverna Therapeutics, Inc. | 546.70M | 7.28% | 778,211 | - |
| 483 | CABA | Cabaletta Bio, Inc. | 545.94M | 3.87% | 3,970,737 | - |
| 484 | TCMD | Tactile Systems Technology, Inc. | 534.14M | 0.94% | 309,010 | 350.31M |
| 485 | RZLT | Rezolute, Inc. | 523.38M | - | 1,798,768 | - |
| 486 | PROK | ProKidney Corp. | 523.02M | 7.45% | 751,688 | 818.00K |
| 487 | CLPT | ClearPoint Neuro, Inc. | 517.35M | 11.80% | 1,081,430 | 42.28M |
| 488 | CCCC | C4 Therapeutics, Inc. | 516.71M | 2.44% | 4,286,015 | 35.04M |
| 489 | DNA | Ginkgo Bioworks Holdings, Inc. | 507.75M | 11.21% | 1,681,863 | 132.42M |
| 490 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 491 | EDIT | Editas Medicine, Inc. | 503.74M | 9.33% | 4,212,991 | 47.01M |
| 492 | SENS | Senseonics Holdings, Inc. | 503.36M | 1.49% | 598,358 | 48.55M |
| 493 | EVMN | Evommune, Inc. | 500.47M | 0.88% | 340,384 | 10.00M |
| 494 | KMDA | Kamada Ltd. | 489.99M | 2.37% | 121,682 | 191.85M |
| 495 | RLMD | Relmada Therapeutics, Inc. | 489.61M | 0.22% | 1,025,381 | - |
| 496 | NRC | NRC Health | 487.07M | 0.46% | 53,813 | 140.00M |
| 497 | NPCE | NeuroPace, Inc. | 486.03M | 1.22% | 153,402 | 106.99M |
| 498 | QTTB | Q32 Bio Inc. | 485.84M | -0.24% | 598,987 | 53.74M |
| 499 | EPRX | Eupraxia Pharmaceuticals Inc. | 485.68M | 1.92% | 562,243 | - |
| 500 | PRTA | Prothena Corporation plc | 483.59M | 0.32% | 363,694 | 54.53M |